x

Posted 24 January, 2024

MedMen Enterprises, Inc. appointed new CEO

CEO Change detected for ticker OTC:MMNFF in a 8-K filed on 24 January, 2024.


  On January 19, 2024, Ellen Harrison notified the board of directors (the "Board") of MedMen Enterprises Inc. (the "Company") of her resignation from her positions as the Company's Chief Executive Officer and as a member of the Board, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of MedMen Enterprises, Inc.
N/A • N/A

Market Cap
$15.5M
View Company Details
MedMen Enterprises, Inc. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On January 19, 2024, Ellen Harrison notified the board of directors (the "Board") of MedMen Enterprises Inc. (the "Company") of her resignation from her positions as the Company's Chief Executive Officer and as a member of the Board, effective immediately. Ms. Harrison's resignation was not the result of any disagreements with the Company on any matter related to the operations, policies, or practices of the Company.


On January 24, 2024, Michael Serruya, the Executive Chairman of the Board, who has served on the Board since August 2021, also resigned from the Board, effective immediately. Upon the effectiveness of his resignation, Mr. Serruya also ceased to serve on any Board committees, including as a member and Chairman of the Nominating & Corporate Governance Committee and as a member of the Audit Committee and the Compensation Committee. Mr. Serruya's resignation was not the result of any disagreements with the Company on any matter related to the operations, policies, or practices of the Company.